Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BELLUS Health Inc BLUSD


Primary Symbol: T.BLU

BELLUS Health Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. The Company's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The Company has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The Company is focused on initiating Phase III program. The Company is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.


TSX:BLU - Post by User

Bullboard Posts
Post by webpiloton May 01, 2012 4:02pm
324 Views
Post# 19858310

Why?

Why?

With no news forever and forever is a long long time, why would Pharmascience Inc put 18 million dollars into this company.  For one thing the stock price does not reflect any value whatsoever, I think we can all agree on that.  So, what does Pharmascience Inc know that we don't know.  This is after Celtic has also invested heavily.  

Something big must be on the way, Pharmascience Inc appears to be a big pill manufacturer along with other things. 

I guess everything has worked out perfectly for some, including the low conversion price.  Most of us will lose large amounts of money with little chance of getting it back because of the reverse split.

Also Vivimind has had sales in Canada for a long time and significant sales in Europe yet I have never seen any revenue except for an isolated case flow down to or ever stated on the financial reports that should have occured with the sale of the raw materials by Bellus to the distributors and owners of Vivimind or Vivimind franchises.

I guess we will just have to stand by and take our medicine.

 

Bullboard Posts